NovMetaPharma decides on paid-in capital increase
노브메타파마
229500
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=2680
Risk-adjusted indicator based on 2680 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Subscription Date: June 17, 2026
- • Payment Date: June 25, 2026
- • Discount Rate: 10%
- • Lock-up Period: 1 year from listing date
AI Analysis Summary
NovMetaPharma Co., Ltd. has decided on a paid-in capital increase, with a subscription date of June 17, 2026, and a payment date of June 25, 2026. The new share issuance price will be determined by applying a 10% discount to the weighted average stock price from the 3rd to 5th trading days prior to the subscription date. The newly issued shares will be subject to a one-year lock-up period from the listing date. This capital increase is likely to dilute existing shareholder value.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.